http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc 2026-05-11T19:07:39Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=2026770&oldid=prev 2026-04-16T04:37:19Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2026年4月16日 (四) 04:37的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

KGadmin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=2008848&oldid=prev 2026-04-15T13:19:27Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2026年4月15日 (三) 13:19的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >第5行：</td> <td colspan="2" class="diff-lineno">第5行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">系统性硬化症纤维化机制相关信号通路的研究进展</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">肠道菌群与系统性硬化症相互作用研究进展</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]](systemic <del class="diffchange diffchange-inline">sclerosis，</del>[[SSc]])<del class="diffchange diffchange-inline">是一种复杂的慢性免疫系统疾病，可导致全身多处组织和器官纤维化。</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]](systemic <ins class="diffchange diffchange-inline">sclerosis,</ins>[[SSc]])<ins class="diffchange diffchange-inline">是一种自身免疫性疾病,该病发病原因不明,主要临床表现为皮肤增厚和变硬、血管病变、纤维化,并伴随心肺肾等内脏器官及消化道受累,而胃肠道易受到影响,在疾病发展中,大多数患者的正常胃肠功能逐渐出现了功能</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">浆细胞样树突状细胞在系统性硬化症中的研究进展</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">30例系统性硬化症肺功能分析</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]](<del class="diffchange diffchange-inline">systemic sclerosis，</del>[[SSc]])<del class="diffchange diffchange-inline">是一种以免疫失调、血管病变和进行性皮肤及内脏器官纤维化为特征的自身免疫性疾病。</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">为研究</ins>[[系统性硬化症]]([[SSc]])<ins class="diffchange diffchange-inline">导致肺功能损害的早期改变.</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">人间充质干细胞治疗系统性硬化症的研究进展</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">单核细胞趋化蛋白-1在系统性硬化症患者中的表达</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]]<del class="diffchange diffchange-inline">（</del>[[SSc]]<del class="diffchange diffchange-inline">）是一种罕见且累及全身多脏器的自身免疫性疾病。</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">目的 探讨单核细胞趋化蛋白-1(MCP-1)在</ins>[[系统性硬化症]]<ins class="diffchange diffchange-inline">(</ins>[[SSc]]<ins class="diffchange diffchange-inline">)的相关性.</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">自身炎症性疾病和自身免疫病</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">系统性硬化症肺部病变的临床特征及病理特点</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">AD亦分为单基因病和多基因病，后者包括类风湿关节炎</del>(<del class="diffchange diffchange-inline">小eumatojdanbtis，RA</del>)、系统性红斑狼疮(<del class="diffchange diffchange-inline">systeIIliclupusq，tllematosus，SLE</del>)<del class="diffchange diffchange-inline">、</del>[[系统性硬化症]](<del class="diffchange diffchange-inline">sy8tematicsclerosis，</del>[[SSc]])<del class="diffchange diffchange-inline">、多发性肌炎／皮肌炎(polymyositis，demmtomyositis，PM，DM)、干燥综合征</del>(<del class="diffchange diffchange-inline">Sj噼n’ssyndro眦，SS</del>)<del class="diffchange diffchange-inline">、混合型结缔组织病</del>(<del class="diffchange diffchange-inline">IIlixedconnectivetissuedisease，MCTD</del>)<del class="diffchange diffchange-inline">、未分化结缔组织病</del>(<del class="diffchange diffchange-inline">undi＆rentiatedconnectivetissuediseases，uCTD</del>)<del class="diffchange diffchange-inline">、系统性血管炎和重叠综合征等。</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">目的:了解[[系统性硬化症]]([[SSc]])患者肺部病变的临床特征及病理特点.</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">===结缔组织病相关的肺动脉高压研究进展===</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">结缔组织病中最常受累的是[[系统性硬化症]]([[SSc]]),而混合性结缔组织病</ins>(<ins class="diffchange diffchange-inline">MCTD</ins>)、系统性红斑狼疮(<ins class="diffchange diffchange-inline">SLE</ins>)<ins class="diffchange diffchange-inline">及炎性肌病包括多肌炎和皮肌炎也常被累及.</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">===结缔组织病肺间质纤维化的临床分析===</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">结果 CTD-PF总发生率3.8%,其中</ins>[[系统性硬化症]]([[SSc]])<ins class="diffchange diffchange-inline">、混合性结缔组织</ins>(<ins class="diffchange diffchange-inline">MCTD</ins>)<ins class="diffchange diffchange-inline">的发生率最高,临床表现以雷诺氏征、干咳、胸闷气急为主,合并肺部感染、肺动脉高压</ins>(<ins class="diffchange diffchange-inline">PAH</ins>)<ins class="diffchange diffchange-inline">较CTD无PF患者高</ins>(<ins class="diffchange diffchange-inline">P《0.01</ins>)<ins class="diffchange diffchange-inline">,肺功能检查提示弥散性功能障碍、限制性通气</ins></div></td></tr> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=2026769&oldid=prev 2026-04-13T13:56:59Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2026年4月13日 (一) 13:56的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >第5行：</td> <td colspan="2" class="diff-lineno">第5行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">肠道菌群与系统性硬化症相互作用研究进展</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">系统性硬化症纤维化机制相关信号通路的研究进展</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]](systemic <del class="diffchange diffchange-inline">sclerosis,</del>[[SSc]])<del class="diffchange diffchange-inline">是一种自身免疫性疾病,该病发病原因不明,主要临床表现为皮肤增厚和变硬、血管病变、纤维化,并伴随心肺肾等内脏器官及消化道受累,而胃肠道易受到影响,在疾病发展中,大多数患者的正常胃肠功能逐渐出现了功能</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]](systemic <ins class="diffchange diffchange-inline">sclerosis，</ins>[[SSc]])<ins class="diffchange diffchange-inline">是一种复杂的慢性免疫系统疾病，可导致全身多处组织和器官纤维化。</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">30例系统性硬化症肺功能分析</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">浆细胞样树突状细胞在系统性硬化症中的研究进展</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">为研究</del>[[系统性硬化症]]([[SSc]])<del class="diffchange diffchange-inline">导致肺功能损害的早期改变.</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]](<ins class="diffchange diffchange-inline">systemic sclerosis，</ins>[[SSc]])<ins class="diffchange diffchange-inline">是一种以免疫失调、血管病变和进行性皮肤及内脏器官纤维化为特征的自身免疫性疾病。</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">单核细胞趋化蛋白-1在系统性硬化症患者中的表达</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">人间充质干细胞治疗系统性硬化症的研究进展</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">目的 探讨单核细胞趋化蛋白-1(MCP-1)在</del>[[系统性硬化症]]<del class="diffchange diffchange-inline">(</del>[[SSc]]<del class="diffchange diffchange-inline">)的相关性.</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]]<ins class="diffchange diffchange-inline">（</ins>[[SSc]]<ins class="diffchange diffchange-inline">）是一种罕见且累及全身多脏器的自身免疫性疾病。</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">系统性硬化症肺部病变的临床特征及病理特点</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">自身炎症性疾病和自身免疫病</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">目的:了解[[系统性硬化症]]([[SSc]])患者肺部病变的临床特征及病理特点.</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">AD亦分为单基因病和多基因病，后者包括类风湿关节炎</ins>(<ins class="diffchange diffchange-inline">小eumatojdanbtis，RA</ins>)、系统性红斑狼疮(<ins class="diffchange diffchange-inline">systeIIliclupusq，tllematosus，SLE</ins>)<ins class="diffchange diffchange-inline">、</ins>[[系统性硬化症]](<ins class="diffchange diffchange-inline">sy8tematicsclerosis，</ins>[[SSc]])<ins class="diffchange diffchange-inline">、多发性肌炎／皮肌炎(polymyositis，demmtomyositis，PM，DM)、干燥综合征</ins>(<ins class="diffchange diffchange-inline">Sj噼n’ssyndro眦，SS</ins>)<ins class="diffchange diffchange-inline">、混合型结缔组织病</ins>(<ins class="diffchange diffchange-inline">IIlixedconnectivetissuedisease，MCTD</ins>)<ins class="diffchange diffchange-inline">、未分化结缔组织病</ins>(<ins class="diffchange diffchange-inline">undi＆rentiatedconnectivetissuediseases，uCTD</ins>)<ins class="diffchange diffchange-inline">、系统性血管炎和重叠综合征等。</ins></div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">===结缔组织病相关的肺动脉高压研究进展===</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">结缔组织病中最常受累的是[[系统性硬化症]]([[SSc]]),而混合性结缔组织病</del>(<del class="diffchange diffchange-inline">MCTD</del>)、系统性红斑狼疮(<del class="diffchange diffchange-inline">SLE</del>)<del class="diffchange diffchange-inline">及炎性肌病包括多肌炎和皮肌炎也常被累及.</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">===结缔组织病肺间质纤维化的临床分析===</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">结果 CTD-PF总发生率3.8%,其中</del>[[系统性硬化症]]([[SSc]])<del class="diffchange diffchange-inline">、混合性结缔组织</del>(<del class="diffchange diffchange-inline">MCTD</del>)<del class="diffchange diffchange-inline">的发生率最高,临床表现以雷诺氏征、干咳、胸闷气急为主,合并肺部感染、肺动脉高压</del>(<del class="diffchange diffchange-inline">PAH</del>)<del class="diffchange diffchange-inline">较CTD无PF患者高</del>(<del class="diffchange diffchange-inline">P《0.01</del>)<del class="diffchange diffchange-inline">,肺功能检查提示弥散性功能障碍、限制性通气</del></div></td><td colspan="2">&#160;</td></tr> </table>

Admin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=2008847&oldid=prev 2026-04-13T13:56:59Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2026年4月13日 (一) 13:56的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >第1行：</td> <td colspan="2" class="diff-lineno">第1行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>主实体：[[系统性硬化症]]，关系：[[同义词]] ，尾实体：[[SSc]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>主实体：[[系统性硬化症]]，关系：[[同义词]] ，尾实体：[[SSc]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">实体ID:''141584''</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==关系介绍==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==关系介绍==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>待补充</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>待补充</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">肠道菌群与系统性硬化症相互作用研究进展（中华医学会文献）</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">肠道菌群与系统性硬化症相互作用研究进展</ins>===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]](systemic sclerosis,[[SSc]])是一种自身免疫性疾病,该病发病原因不明,主要临床表现为皮肤增厚和变硬、血管病变、纤维化,并伴随心肺肾等内脏器官及消化道受累,而胃肠道易受到影响,在疾病发展中,大多数患者的正常胃肠功能逐渐出现了功能</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>[[系统性硬化症]](systemic sclerosis,[[SSc]])是一种自身免疫性疾病,该病发病原因不明,主要临床表现为皮肤增厚和变硬、血管病变、纤维化,并伴随心肺肾等内脏器官及消化道受累,而胃肠道易受到影响,在疾病发展中,大多数患者的正常胃肠功能逐渐出现了功能</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">30例系统性硬化症肺功能分析（中华医学会文献）</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">30例系统性硬化症肺功能分析</ins>===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>为研究[[系统性硬化症]]([[SSc]])导致肺功能损害的早期改变.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>为研究[[系统性硬化症]]([[SSc]])导致肺功能损害的早期改变.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===单核细胞趋化蛋白-<del class="diffchange diffchange-inline">1在系统性硬化症患者中的表达（中华医学会文献）</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===单核细胞趋化蛋白-<ins class="diffchange diffchange-inline">1在系统性硬化症患者中的表达</ins>===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>目的 探讨单核细胞趋化蛋白-1(MCP-1)在[[系统性硬化症]]([[SSc]])的相关性.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>目的 探讨单核细胞趋化蛋白-1(MCP-1)在[[系统性硬化症]]([[SSc]])的相关性.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">系统性硬化症肺部病变的临床特征及病理特点（中华医学会文献）</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">系统性硬化症肺部病变的临床特征及病理特点</ins>===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>目的:了解[[系统性硬化症]]([[SSc]])患者肺部病变的临床特征及病理特点.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>目的:了解[[系统性硬化症]]([[SSc]])患者肺部病变的临床特征及病理特点.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">结缔组织病相关的肺动脉高压研究进展（中华医学会文献）</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">结缔组织病相关的肺动脉高压研究进展</ins>===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>结缔组织病中最常受累的是[[系统性硬化症]]([[SSc]]),而混合性结缔组织病(MCTD)、系统性红斑狼疮(SLE)及炎性肌病包括多肌炎和皮肌炎也常被累及.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>结缔组织病中最常受累的是[[系统性硬化症]]([[SSc]]),而混合性结缔组织病(MCTD)、系统性红斑狼疮(SLE)及炎性肌病包括多肌炎和皮肌炎也常被累及.</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">===结缔组织病肺间质纤维化的临床分析===</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">结果 CTD-PF总发生率3.8%,其中[[系统性硬化症]]([[SSc]])、混合性结缔组织(MCTD)的发生率最高,临床表现以雷诺氏征、干咳、胸闷气急为主,合并肺部感染、肺动脉高压(PAH)较CTD无PF患者高(P《0.01),肺功能检查提示弥散性功能障碍、限制性通气</ins></div></td></tr> </table>

Admin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=1915730&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=1915731&oldid=prev 2024-07-06T13:39:55Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 13:39的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

KGadmin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=1083117&oldid=prev 2024-07-05T13:54:38Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月5日 (五) 13:54的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

KGadmin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=1018828&oldid=prev 2024-05-24T03:42:54Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年5月24日 (五) 03:42的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

KGadmin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=1083116&oldid=prev 2022-09-22T13:56:59Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2022年9月22日 (四) 13:56的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%87-%E5%90%8C%E4%B9%89%E8%AF%8D-SSc&diff=1018827&oldid=prev 2022-09-22T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[系统性硬化症]]，关系：[[同义词]] ，尾实体：[[SSc]]<br /> <br /> 实体ID:''141584''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===肠道菌群与系统性硬化症相互作用研究进展（中华医学会文献）===<br /> [[系统性硬化症]](systemic sclerosis,[[SSc]])是一种自身免疫性疾病,该病发病原因不明,主要临床表现为皮肤增厚和变硬、血管病变、纤维化,并伴随心肺肾等内脏器官及消化道受累,而胃肠道易受到影响,在疾病发展中,大多数患者的正常胃肠功能逐渐出现了功能<br /> <br /> ===30例系统性硬化症肺功能分析（中华医学会文献）===<br /> 为研究[[系统性硬化症]]([[SSc]])导致肺功能损害的早期改变.<br /> <br /> ===单核细胞趋化蛋白-1在系统性硬化症患者中的表达（中华医学会文献）===<br /> 目的 探讨单核细胞趋化蛋白-1(MCP-1)在[[系统性硬化症]]([[SSc]])的相关性.<br /> <br /> ===系统性硬化症肺部病变的临床特征及病理特点（中华医学会文献）===<br /> 目的:了解[[系统性硬化症]]([[SSc]])患者肺部病变的临床特征及病理特点.<br /> <br /> ===结缔组织病相关的肺动脉高压研究进展（中华医学会文献）===<br /> 结缔组织病中最常受累的是[[系统性硬化症]]([[SSc]]),而混合性结缔组织病(MCTD)、系统性红斑狼疮(SLE)及炎性肌病包括多肌炎和皮肌炎也常被累及.</div>

Admin